BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 25403448)

  • 1. Null cell adenomas of the pituitary gland: an institutional review of their clinical imaging and behavioral characteristics.
    Balogun JA; Monsalves E; Juraschka K; Parvez K; Kucharczyk W; Mete O; Gentili F; Zadeh G
    Endocr Pathol; 2015 Mar; 26(1):63-70. PubMed ID: 25403448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and outcomes of null-cell versus silent gonadotroph adenomas in a series of 1166 pituitary adenomas from a single institution.
    Haddad AF; Young JS; Oh T; Pereira MP; Joshi RS; Pereira KM; Osorio RC; Donohue KC; Peeran Z; Sudhir S; Jain S; Beniwal A; Chopra AS; Sandhu NS; Theodosopoulos PV; Kunwar S; El-Sayed IH; Gurrola J; Blevins LS; Aghi MK
    Neurosurg Focus; 2020 Jun; 48(6):E13. PubMed ID: 32480370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, pathologic, and imaging characteristics of pituitary null cell adenomas as defined according to the 2017 World Health Organization criteria: a case series from two pituitary centers.
    Almeida JP; Stephens CC; Eschbacher JM; Felicella MM; Yuen KCJ; White WL; Mooney MA; Bernat AL; Mete O; Zadeh G; Gentili F; Little AS
    Pituitary; 2019 Oct; 22(5):514-519. PubMed ID: 31401793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between histological subtypes and MRI findings in clinically nonfunctioning pituitary adenomas.
    Nishioka H; Inoshita N; Sano T; Fukuhara N; Yamada S
    Endocr Pathol; 2012 Sep; 23(3):151-6. PubMed ID: 22569896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
    Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index.
    Tanaka Y; Hongo K; Tada T; Sakai K; Kakizawa Y; Kobayashi S
    J Neurosurg; 2003 Feb; 98(2):359-65. PubMed ID: 12593623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth patterns of pituitary adenomas and histopathological correlates.
    Monsalves E; Larjani S; Loyola Godoy B; Juraschka K; Carvalho F; Kucharczyk W; Kulkarni A; Mete O; Gentili F; Ezzat S; Zadeh G
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1330-8. PubMed ID: 24423330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic endonasal transsphenoidal approach to large and giant pituitary adenomas: institutional experience and predictors of extent of resection.
    Juraschka K; Khan OH; Godoy BL; Monsalves E; Kilian A; Krischek B; Ghare A; Vescan A; Gentili F; Zadeh G
    J Neurosurg; 2014 Jul; 121(1):75-83. PubMed ID: 24785323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of endoscopy for maximizing tumor removal in endonasal transsphenoidal pituitary adenoma surgery.
    McLaughlin N; Eisenberg AA; Cohan P; Chaloner CB; Kelly DF
    J Neurosurg; 2013 Mar; 118(3):613-20. PubMed ID: 23240699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological correlates of extrasellar growth patterns in pituitary adenomas.
    Sarkar S; Chacko AG; Chacko G
    J Clin Neurosci; 2015 Jul; 22(7):1173-7. PubMed ID: 25979255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
    Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
    J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of magnetic resonance imaging criteria for cavernous sinus invasion in patients with pituitary adenomas: logistic regression analysis and correlation with surgical findings.
    Vieira JO; Cukiert A; Liberman B
    Surg Neurol; 2006 Feb; 65(2):130-5; discussion 135. PubMed ID: 16427401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic endonasal surgery for giant pituitary adenomas: advantages and limitations.
    Koutourousiou M; Gardner PA; Fernandez-Miranda JC; Paluzzi A; Wang EW; Snyderman CH
    J Neurosurg; 2013 Mar; 118(3):621-31. PubMed ID: 23289816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
    Saeger W; Lüdecke B; Lüdecke DK
    Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR-appearance of the pituitary gland before and after resection of pituitary macroadenomas.
    Steiner E; Math G; Knosp E; Mostbeck G; Kramer J; Herold CJ
    Clin Radiol; 1994 Aug; 49(8):524-30. PubMed ID: 7955862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progression.
    Widhalm G; Wolfsberger S; Preusser M; Fischer I; Woehrer A; Wunderer J; Hainfellner JA; Knosp E
    J Neurosurg; 2009 Sep; 111(3):563-71. PubMed ID: 18991501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor shrinkage after transsphenoidal surgery for nonfunctioning pituitary adenoma.
    Berkmann S; Schlaffer S; Buchfelder M
    J Neurosurg; 2013 Dec; 119(6):1447-52. PubMed ID: 24074495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical pituitary adenomas: incidence, clinical characteristics, and implications.
    Zada G; Woodmansee WW; Ramkissoon S; Amadio J; Nose V; Laws ER
    J Neurosurg; 2011 Feb; 114(2):336-44. PubMed ID: 20868211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging and biological markers in pituitary adenomas with invasion of the cavernous sinus space.
    Pan LX; Chen ZP; Liu YS; Zhao JH
    J Neurooncol; 2005 Aug; 74(1):71-6. PubMed ID: 16078111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.